The CDMO, with 3,200 employees at 20 locations in the U.S., Europe and India, has a global footprint to help customers navigate their R&D and manufacturing challenges.
The privately held contract manufacturer and packager of pharmaceutical and nutraceutical products has tried again to buy Montreal-based Theratechnologies.
The building at its Takasaki, Japan plant will support early-phase development of biopharmaceuticals and includes both GMP-compliant and pilot-scale manufacturing areas.
